need for more judicious prescribing of opioids, and closer
monitoring of those who are prescribed these drugs.
Acknowledgements: This study was funded by the Centers for
Disease Control and Prevention and the Utah Department of Health.
The findings and conclusions in this report are those of the authors
and do not necessarily represent the official position of the Centers
for Disease Control and Prevention. We express our appreciation to
the next of kin of best contacts that consented to be interviewed
after the death of a relative or friend as a result of a drug overdose.
Conflict of Interest: The authors declare that they do not have a
conflict of interest.
Corresponding Author: Ray M. Merrill, PhD, MPH, MS, FACE,
FAAHB; Department of Health Science, Brigham Young University,
Provo, UT 84602, USA (e-mail: Ray_Merrill@byu.edu).
1. Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well
as abuse. JAMA. 2007;297(3):249–51.
2. Centers for Disease Control and Prevention. Vital signs: overdoses of
prescription opioid pain relievers—United States, 1999–2008. MMWR.
3. Centers for Disease Control and Prevention. CDC taking steps to combat
opioid deaths. Available at: http://asam-365.ascendeventmedia. com/
Highlight.aspx?id=4452&p=368. Accessed July 23, 2012.
4. Centers for Disease Control and Prevention. Prescription painkiller
overdoses in the U.S. Available at: http://www.cdc.gov/Features/Vital
signs/PainkillerOverdoses/. Accessed July 23, 2012.
5. Schonfeld L, King-Kallimanis BL, Duchene DM, et al. Screening and
brief intervention for substance misuse among older adults: the Florida
BRITE project. Am J Public Health. 2010;100(1):108–14.
6. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain
medicine: a rational approach to the treatment of chronic pain. Pain
7. White AG, Birnbaum HG, Schiller M, Tang J, Katz NP. Analytic models
to identify patients at risk for prescription opioid abuse. Am J Manag
8. Braden JB, Russo J, Fan MY, et al. Emergency department visits
among recipients of chronic opioid therapy. Arch Intern Med. 2010;170
9. Centers for Disease Control and Prevention. Increase in poisoning
deaths c aused by non-illi cit drug s—Utah, 1991– 2003. MMWR.
10. Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al.
Patterns of abuse among unintentional pharmaceutical overdose fatal-
ities. JAMA. 2008;300(22):2613–20.
11. Jamison RN, Butler SF, Budman SH, Edwards RR, Wasan AD. Gender
differences in risk factors for aberrant prescription opioid use. J Pain.
12. Utah Health Code. Available at: http://le.utah.gov/code/TITLE26/htm/
26_04_000700.htm. Accessed July 28, 2012.
13. U.S. Census Bureau. Available at: http://factfinder2.census.gov/faces/
nav/jsf/pages/searchresults.xhtml?refresh=t. Accessed July 30, 2012.
14. Centers for Disease Control and Prevention. Prevalence and Trends
Data: All States 2009. Available at: http://apps.nccd.cdc.gov/BRFSS/
page.asp?cat=OB&yr=2009&state=All#OB. Accessed July 30, 2012.
15. U.S. Census Bureau. Current Population Survey, 1960 to 2010 Annual
Social and Economic Supplements. Available at: http://www.census.gov/
hhes/www/poverty/data/incpovhlth/2009/pov09fig04.pdf. Accessed Ju-
ly 30, 2012.
16. DeNavas-Walt C, Proctor BD, Smith JC. U.S. Census Bureau, Current
Population Reports, P60-238. Income, Poverty, and Health Insurance
Coverage in the United States: 2009. Washington, DC: U.S. Government
Printing Office; 2010.
17. National Center for Health Statistics. Health, United States, 2011: With
Special Feature on Socioeconomic Status and Health. Hyattsville, MD.
2012. Table 54. Available a t: http://www.cdc.gov/nchs/data/hus/
hus11.pdf. Accessed July 24, 2012.
18. Kessler RC, Angermeyer M, Anthony JC, et al. Lifetime prevalence
and age-of-onset distributions of mental disorders in the World Health
Organization’s World Mental Health Survey Initiative. World Psychiatry.
19. Substance Abuse and Mental Health Services Administration. State
Estimates of Substance Use and Mental Disorders from the 2008–2009
National Surveys on Drug Use and Health, NSDUH Series H-40, HHS
Publication No. (SMA) 11-4641. Rockville, MD: Substance Abuse and
Mental Health Services Administration, 2011.
20. Substance Abuse & Mental Health Data Archive. For the National Survey
on Drug Use and Health, 2009. A vailable at: http://www .icpsr .umich.edu/
quicktables/quickconfig.do?29621-0001_du. Accessed July 24, 2012.
21. Reeves WC, Strine TW, Pratt LA, et al. Mental illness surveillance
among adults in the United States. Available at: http://www.cdc.gov/
Accessed July 24, 2012.
22. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and
comorbidity of twelve-month DSM-IV disorders in the National Comor-
bidity Survey Replication (NCS-R). Arch Gen Psychiatry. 2005;62(6):617–
23. Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of
opioid misuse in patients with chronic pain: a prospective cohort study.
BMC Health Serv Res. 2006;6:46.
24. Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk
factors for clinically recognized opioid abuse and dependence among
veterans using opioids for chro nic non-c ancer pai n. Pain. 2 007;129
25. Grattan A, Sullivan MD, Saunders KW, Campbell CI, Von Korff MR.
Depression and prescri ption opio id misuse amon g chronic opioid
therapy recipients with no history of substance abuse. Ann Fam Med.
26. Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM.
Long-term analgesic use after low-risk surgery: a retrospective cohort
study. Arch Intern Med. 2012;172(5):425–30.
27. Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders
with prescription opioids and high-risk opioid use in US veterans of Iraq
and Afghanistan. JAMA. 2012;307(9):940–7.
28. Bates C, Laciak R, Southwick A, Bishoff J. Ove rprescription of
postoperative narcotics: a look at postoperative pain medication delivery,
consumption and disposal in urological practice. J Urol. 2011;185
29. Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring
program and death rates from drug overdose. Pain Med. 2011;12(5):747–
30. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid
prescribing patterns and opioid overdose-related deaths. JAMA.
31. Edlund MJ, Martin BC, Fan MY, Devries A, Braden JB, Sullivan MD.
Risks for opioid abuse and dependence among recipients of chronic
opioid therapy: results from the TROUP study. Drug Alcohol Depend.
32. McLellan AT, Turner BJ. Chronic noncancer pain management and
opioid overdose: time to change prescribing practices. Ann Intern Med.
33. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO,
Sullivan MD, et al.
Opioid prescriptions for chronic pain and overdose: a
cohort study. Ann Intern Med. 2010;152(2):85–92.
34. Toblin RL, Paulozzi LJ, Logan JE, Hall AJ, Kaplan JA. Mental illness
and psychotropic drug use among prescription drug overdose deaths: a
medical examiner chart review. J Clin Psychiatry. 2010;71(4):491–6.
35. Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior
in patients treated for chronic pain: importance of abuse history. J Pain
Symptom Manage. 2004;28(3):250–8.
36. Utah Department of Health, Center for Health Data Indicator-Based
Information System for Public Health. Percentage of adults who reported
current cigarette smoking by education, Utah adults aged 25 and older,
2009; 2011. Available at: http://ibis.health.utah.gov/indicator/view/
CigSmokAdlt.Edu.html. Accessed 5 January, 2012.
37. Centers for Disease Control and Prevention. State-specific prevalance of
cigarette smoking and smokeless tobacco use among adults—United
States, 2009. MMWR. 2010;59(43):1400–6.
38. Wiesbeck GA, Kuhl HC, Yaldizli O, Wurst FM, WHO/ISBRA Study
Group on Biological State and Trait Markers of Alcohol Use and
Johnson et al.: Opioid-Related DeathsJGIM